Literature DB >> 3143697

Diarrhetic shellfish toxin, dinophysistoxin-1, is a potent tumor promoter on mouse skin.

H Fujiki1, M Suganuma, H Suguri, S Yoshizawa, K Takagi, N Uda, K Wakamatsu, K Yamada, M Murata, T Yasumoto.   

Abstract

Dinophysistoxin-1, 35-methylokadaic acid, is a causative agent of diarrhetic shellfish poisoning. The biological activities and tumor-promoting activity of dinophysistoxin-1 were studied together with those of okadaic acid and 7-O-palmitoyl okadaic acid. Dinophysistoxin-1 is a skin irritant and induces ornithine decarboxylase in mouse skin with the same potency as okadaic acid. 7-O-Palmitoyl okadaic acid induced a lower activity than the other compounds. Dinophysistoxin-1 inhibited the specific [3H]okadaic acid binding to a particulate fraction of mouse epidermis. The binding affinities of dinophysistoxin-1 and okadaic acid to a particulate fraction were almost the same. Dinophysistoxin-1 showed a tumor-promoting activity as strong as that of okadaic acid in a two-stage carcinogenesis experiment on mouse skin. The percentages of tumor-bearing mice in the groups treated with 100 micrograms of 7,12-dimethylbenz[a]anthracene (DMBA) followed by 5 micrograms of dinophysistoxin-1, twice a week, and with DMBA followed by 5 micrograms of okadaic acid twice a week were 86.7% and 80.0% in week 30, respectively. The average number of tumors per mouse was 4.6 in the former group and 3.9 in the latter. Dinophysistoxin-1 and okadaic acid act on cells through different pathways from the 12-O-tetradecanoylphorbol-13-acetate-type tumor promoters.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3143697      PMCID: PMC5917631          DOI: 10.1111/j.1349-7006.1988.tb01531.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  6 in total

Review 1.  New classes of tumor promoters: teleocidin, aplysiatoxin, and palytoxin.

Authors:  H Fujiki; T Sugimura
Journal:  Adv Cancer Res       Date:  1987       Impact factor: 6.242

2.  Production of antibodies and development of a radioimmunoassay for okadaic acid.

Authors:  L Levine; H Fujiki; K Yamada; M Ojika; H B Gjika; H Van Vunakis
Journal:  Toxicon       Date:  1988       Impact factor: 3.033

3.  Indole alkaloids: dihydroteleocidin B, teleocidin, and lyngbyatoxin A as members of a new class of tumor promoters.

Authors:  H Fujiki; M Mori; M Nakayasu; M Terada; T Sugimura; R E Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

4.  Histopathological studies on experimental marine toxin poisoning. I. Ultrastructural changes in the small intestine and liver of suckling mice induced by dinophysistoxin-1 and pectenotoxin-1.

Authors:  K Terao; E Ito; T Yanagi; T Yasumoto
Journal:  Toxicon       Date:  1986       Impact factor: 3.033

5.  Teleocidin from Streptomyces is a potent promoter of mouse skin carcinogenesis.

Authors:  H Fujiki; M Suganuma; N Matsukura; T Sugimura; S Takayama
Journal:  Carcinogenesis       Date:  1982       Impact factor: 4.944

6.  Okadaic acid: an additional non-phorbol-12-tetradecanoate-13-acetate-type tumor promoter.

Authors:  M Suganuma; H Fujiki; H Suguri; S Yoshizawa; M Hirota; M Nakayasu; M Ojika; K Wakamatsu; K Yamada; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

  6 in total
  26 in total

1.  Cytoskeletal integrity in interphase cells requires protein phosphatase activity.

Authors:  J E Eriksson; D L Brautigan; R Vallee; J Olmsted; H Fujiki; R D Goldman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

2.  Tautomycin: an inhibitor of protein phosphatases 1 and 2A but not a tumor promoter on mouse skin and in rat glandular stomach.

Authors:  M Suganuma; S Okabe; E Sueoka; R Nishiwaki; A Komori; N Uda; K Isono; H Fujiki
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

3.  Stimulation of prostaglandin E2 production and induction of specific protein synthesis in rat peritoneal macrophages by a tumor promoter staurosporine.

Authors:  T Tamura; M Watanabe; N Hirasawa; S Mue; K Ohuchi
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

4.  Increase of labeling indices in gastrointestinal mucosae of mice and rats by compounds of the okadaic acid type.

Authors:  H Yuasa; K Yoshida; H Iwata; H Nakanishi; M Suganuma; M Tatematsu
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

5.  In vitro acylation of okadaic acid in the presence of various bivalves' extracts.

Authors:  Keiichi Konoki; Tatsuya Onoda; Ryuichi Watanabe; Yuko Cho; Shinnosuke Kaga; Toshiyuki Suzuki; Mari Yotsu-Yamashita
Journal:  Mar Drugs       Date:  2013-01-29       Impact factor: 5.118

6.  Use of biosensors as alternatives to current regulatory methods for marine biotoxins.

Authors:  Natalia Vilariño; Eva S Fonfría; M Carmen Louzao; Luis M Botana
Journal:  Sensors (Basel)       Date:  2009-11-24       Impact factor: 3.576

7.  Identification of differentially expressed genes in SHSY5Y cells exposed to okadaic acid by suppression subtractive hybridization.

Authors:  Vanessa Valdiglesias; Juan Fernández-Tajes; Eduardo Pásaro; Josefina Méndez; Blanca Laffon
Journal:  BMC Genomics       Date:  2012-01-27       Impact factor: 3.969

Review 8.  Testing electromagnetic fields for potential carcinogenic activity: a critical review of animal models.

Authors:  J McCann; R Kavet; C N Rafferty
Journal:  Environ Health Perspect       Date:  1997-02       Impact factor: 9.031

9.  Mechanisms of action of okadaic acid class tumor promoters on mouse skin.

Authors:  H Fujiki; M Suganuma; S Yoshizawa; S Nishiwaki; B Winyar; T Sugimura
Journal:  Environ Health Perspect       Date:  1991-06       Impact factor: 9.031

Review 10.  Is protein phosphatase inhibition responsible for the toxic effects of okadaic Acid in animals?

Authors:  Rex Munday
Journal:  Toxins (Basel)       Date:  2013-02-04       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.